Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Friday, April 17, 2015, 38 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $235.33 to $30,000,000,000.00.

Highlighted Stocks Traded by Insiders:

FTD Companies (FTD) - FREE Research Report

Armstrong James T, who is Director at FTD Companies, sold 333 shares at $28.83 on April 17, 2015. Following this transaction, the Director owned 17,948 shares meaning that the stake was reduced by 1.82% with the 333-share transaction.

The shares most recently traded at $29.49, up $0.66, or 2.24% since the insider transaction. Historical insider transactions for FTD Companies go as follows:

  • 4-Week # shares sold: 333
  • 12-Week # shares sold: 667
  • 24-Week # shares sold: 5,961

The average volume for FTD Companies has been 168,700 shares per day over the past 30 days. FTD Companies has a market cap of $864.1 million and is part of the services sector and specialty retail industry. Shares are down 15.25% year-to-date as of the close of trading on Friday.

FTD Companies, Inc., through its subsidiaries, operates as a floral and gifting company primarily in the United States, Canada, the United Kingdom, and the Republic of Ireland. The company operates through four segments: Consumer, Florist, International, and Provide Commerce. The company has a P/E ratio of 25.2. Currently, there are 2 analysts who rate FTD Companies a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FTD - FREE

TheStreet Quant Ratings

rates FTD Companies as a

sell

. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself and generally high debt management risk. Get the full

FTD Companies Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Hemispherx Biopharma (HEB) - FREE Research Report

Carter William A, who is Ceo at Hemispherx Biopharma, bought 26,319 shares at $0.23 on April 17, 2015. Following this transaction, the Ceo owned 876,904 shares meaning that the stake was boosted by 3.09% with the 26,319-share transaction.

The shares most recently traded at $0.24, up $0.01, or 4.17% since the insider transaction. Historical insider transactions for Hemispherx Biopharma go as follows:

  • 4-Week # shares bought: 100,000
  • 12-Week # shares bought: 100,000
  • 24-Week # shares bought: 100,000

The average volume for Hemispherx Biopharma has been 1.9 million shares per day over the past 30 days. Hemispherx Biopharma has a market cap of $49.9 million and is part of the health care sector and drugs industry. Shares are down 7.2% year-to-date as of the close of trading on Friday.

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. Currently, there are no analysts who rate Hemispherx Biopharma a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HEB - FREE

TheStreet Quant Ratings

rates Hemispherx Biopharma as a

sell

. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity and generally disappointing historical performance in the stock itself. Get the full

Hemispherx Biopharma Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Allied World Assurance Co Holdings (AWH) - FREE Research Report

Grossack Marshall J, who is EVP, Chief Actuary at Allied World Assurance Co Holdings, sold 2,000 shares at $42.53 on April 17, 2015. Following this transaction, the EVP, Chief Actuary owned 210,440 shares meaning that the stake was reduced by 0.94% with the 2,000-share transaction.

The shares most recently traded at $41.72, down $0.81, or 1.94% since the insider transaction. Historical insider transactions for Allied World Assurance Co Holdings go as follows:

  • 4-Week # shares sold: 750
  • 12-Week # shares sold: 750
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 750

The average volume for Allied World Assurance Co Holdings has been 433,600 shares per day over the past 30 days. Allied World Assurance Co Holdings has a market cap of $4.0 billion and is part of the financial sector and insurance industry. Shares are up 10.44% year-to-date as of the close of trading on Friday.

Allied World Assurance Company Holdings, AG, through its subsidiaries, provides property, casualty, and specialty insurance and reinsurance solutions worldwide. It operates through three segments: North American Insurance, Global Markets Insurance, and Reinsurance. The stock currently has a dividend yield of 2.15%. The company has a P/E ratio of 8.5. Currently, there are 3 analysts who rate Allied World Assurance Co Holdings a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AWH - FREE

TheStreet Quant Ratings

rates Allied World Assurance Co Holdings as a

buy

. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins, notable return on equity and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Allied World Assurance Co Holdings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null